Centessa Pharmaceuticals plc (CNTA)
Jun 24, 2026 - CNTA was delisted (reason: acquired by LLY)
40.50
+0.32 (0.80%)
Inactive · Last trade price
on Jun 23, 2026
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 118 employees as of December 31, 2025. The number of employees increased by 41 or 53.25% compared to the previous year.
Employees
118
Change (1Y)
41
Growth (1Y)
53.25%
Revenue / Employee
n/a
Profits / Employee
-$1,942,930
Market Cap
6.27B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 118 | 41 | 53.25% |
| Dec 31, 2024 | 77 | 1 | 1.32% |
| Dec 31, 2023 | 76 | -7 | -8.43% |
| Dec 31, 2022 | 83 | -7 | -7.78% |
| Dec 31, 2021 | 90 | - | - |
CNTA News
- 4 days ago - Centessa announces High Court approval for acquisition by Eli Lilly - TheFly
- 4 days ago - Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales - GlobeNewsWire
- 22 days ago - Centessa gets FDA orphan drug designation for cleminorexton - TheFly
- 25 days ago - Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development - PRNewsWire
- 7 weeks ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 7 weeks ago - Centessa Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 2 months ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 2 months ago - Centessa downgraded to Equal Weight from Overweight at Wells Fargo - TheFly